- “Cannabis manufacturers that ignore the obvious progression toward an FDA-like industry will not survive the long game,” writes industry expert
- GRYN farm and facilities have already gained USDA Organic certification, FDA registration
- Green Hygienics ideally positioned to innovate, drive new commercial products entirely compliant to USDA and FDA regulatory requirements
As government entities more closely analyze cannabis and the federal regulations that surround the industry, savvy companies such as Green Hygienics (OTCQB: GRYN) are already working to position themselves to offer safe, high-quality products and services. Anticipating what future regulations might look like — and working to meet those guidelines right now — is a hallmark of GRYN.
“Cannabis manufacturers that ignore the obvious progression toward an FDA-like industry will not survive the long game,” writes Kathleen May, a regulatory professional with more than two decades of experience in the Good Manufacturing Practice space, in a recent “Cannabis Industry Journal” article (https://cnw.fm/fklfF). “Those that embrace the momentum and properly plan to mitigate product and business risk — those who demonstrate integrity and are truly in this space to ensure safe, effective and quality products to consumers will come out on top, gain credibility and secure brand recognition.”
Strategic planning and a long-running commitment to quality are hallmarks of Green Hygienics. The company has a track record of working to obtain significant government approvals and certifications. In April 2020, Green Hygienics received USDA Organic Certification for its 824-acre farm, which includes 400,000 square feet of greenhouse space (https://cnw.fm/jeHwp).
The USDA Organic seal is one of the most recognized certifications among U.S. consumers and provides assurance to consumers who may be concerned about the safety of CBD products. In addition to assuring that no synthetic fertilizers, pesticides or herbicides have been used in the cultivation of hemp, the USDA organic certification ensures that farmers are using tillage and cultivation practices that maintain or improve the condition of soil and minimize soil erosion through crop rotations, cover crops and the application of plant and animal materials.
“GRYN owns the largest single, USDA Organic-Certified Industrial Hemp for CBD farms in North America,” said GRYN CEO Ron Loudoun. “Having the capacity to provide a secure supply chain of considerable size is a very significant and a clear strategic advantage. . . . This is a great milestone to have achieved. The demand for organic product is growing rapidly with increasing consumer concerns around product efficacy. USDA Organic Certification is the foundation in our objective to supply the underserved medical and pharmaceutical industry.”
In October 2020, Green Hygienics announced that it was registered with the U.S. Food and Drug Administration pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002 (https://cnw.fm/IelzL).
“The achievement of FDA registration strengthens our company’s core mission to provide product efficacy to the pharmaceutical industry and consumers alike,” said GRYN chief scientific officer Dr. Levan Darjania. “The company is well positioned to instill consumer confidence and change the landscape of the industry by bringing safe and consistent products to market. With our previously announced USDA Organic Certification and FDA Facility Registration, we are well positioned to continue to innovate through the research our teams are involved in and drive new commercial products entirely compliant to USDA and FDA regulatory requirements.”
Clearly Green Hygienics is positioned to come out on top. The California-based, innovative, technology-driven enterprise is focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company aims to be a leader in compliance and capabilities in the hemp and cannabinoid supply marketplace. By leveraging state-of-the-art technologies, GRYN intends to open up a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, thus solving the issues of stability, pharmacokinetics, biological tissue penetration and bioavailability.
For more information, visit the company’s website at www.GreenHygienics.com.
NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.